Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart failure (HF). Current knowledge on incidence, pathophysiology and natural history of HF in cardiomy…
Circadian variation in cardiovascular and metabolic dynamics arises from interactions between intrinsic rhythms and extrinsic cues. By anticipating and accommodating adaptation to awakening and activity,…
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure…
The RevascHeart study. AHF, acute heart failure; CABG, coronary artery bypass graft; CI, confidence interval; CV, cardiovascular; GDMT, guideline-directed medical therapy; LVEDD, left ventricular end…
Return to CVD Roadmaps Home Due to the aging population, increase in cardiovascular risk factors and improved survival of cardiovascular conditions, the prevalence of heart…
Hypertrophic cardiomyopathy (HCM) is one of the most common inherited cardiovascular diseases, with a prevalence between 1:200 and 1:500, affecting more than 20 million people…
Click on the article title to read more.
The H2FPEF score in hypertrophic cardiomyopathy. CI, confidence interval; HCM, hypertrophic cardiomyopathy; LV, left ventricular; sPAP, systolic pulmonary artery pressure.
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure…
Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure…
In the EXPAND study, subjects with prior HFH had an increased incidence of all-cause mortality at 1 year. Associations with 1-year HFH after mitral transcatheter edge-to-edge…
